◄ back to all posts
Financial data and stock pages provided by
Fintel.io
◄ back to all posts
MRSN: Mersana Therapeutics Inc Stock
Written by | Jul 6, 2018SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 1,149.56 |
Enterprise Value ($M) | 933.28 |
Book Value ($M) | 228.09 |
Book Value / Share | 3.30 |
Price / Book | 5.19 |
NCAV ($M) | 213.27 |
NCAV / Share | 3.09 |
Price / NCAV | 5.55 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.38 |
Return on Assets (ROA) | -0.82 |
Return on Equity (ROE) | -1.12 |
Liquidity (mrq) | |
---|---|
Quick Ratio | n/a |
Current Ratio | 8.62 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 258.58 |
Assets | 273.40 |
Liabilities | 45.31 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | n/a |
Net Income | -88.05 |
Earnings Per Share Basic And Diluted | -1.43 |
Earnings Per Share Diluted | -1.43 |
Earnings Per Share Basic | -1.43 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -74.70 |
Cash from Investing | 37.03 |
Cash from Financing | 37.03 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Pfizer Inc | 0.00 | -100.00 | |
13G | Avoro Capital Advisors LLC | 9.90 | ||
13G/A | Biotechnology Value Fund L P | 0.00 | -100.00 | |
13G | Wellington Management Group Llp | 6.79 | 381.23 | |
13G/A | BlackRock Inc. | 11.70 | 0.00 | |
13G | Sarissa Capital Management LP | 5.50 | 0.53 | |
13D/A | Bain Capital Life Sciences Fund II, L.P. | 4.80 | 7.26 | |
13D/A | New Enterprise Associates 14, L.P. | |||
13G/A | ArrowMark Colorado Holdings LLC | 0.00 | -100.00 | |
13G | Venrock Healthcare Capital Partners II, L.P. | 5.20 | 0.00 | |
13G/A | Rock Springs Capital Management LP | 4.31 | -24.63 | |
13G/A | Fmr Llc | 3.88 | ||
13G | Rho Ventures V, L.P. | 5.90 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
Annual Report – 10-K | ||
Quarterly Report – 10-Q | ||
Quarterly Report – 10-Q | ||
Quarterly Report – 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
44,603 | 461,000 | 9.68 | |
65,060 | 712,748 | 9.13 | |
84,218 | 681,338 | 12.36 | |
99,476 | 401,518 | 24.77 | |
(click for more detail) |
|||
(click for list of largest short owners) |
Similar Companies | |
---|---|
MRKR – Marker Therapeutics Inc | MRNA – Moderna Inc |
MRNS – Marinus Pharmaceuticals Inc | MRTX – Mirati Therapeutics Inc |
MRUS – Merus N.V. |
Financial data and stock pages provided by
Fintel.io
2018/07/06